首页> 美国卫生研究院文献>Experimental Diabetes Research >Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana
【2h】

Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana

机译:芬兰糖尿病风险评分在博茨瓦纳普通内科门诊患​​者中发现未诊断的2型糖尿病的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This was a cross-sectional study designed to assess the validity of the Finnish Diabetes Risk Score for detecting undiagnosed type 2 diabetes among general medical outpatients in Botswana. Participants aged ≥20 years without previously diagnosed diabetes were screened by (1) an 8-item Finnish diabetes risk assessment questionnaire and (2) Haemoglobin A1c test. Data from 291 participants were analyzed (74.2% were females). The mean age of the participants was 50.1 (SD = ±11) years, and the prevalence of undiagnosed diabetes was 42 (14.4%) with no significant differences between the gender (20% versus 12.5%, P = 0.26). The area under curve for detecting undiagnosed diabetes was 0.63 (95% CI 0.55–0.72) for the total population, 0.65 (95% CI: 0.56–0.75) for women, and 0.67 (95% CI: 0.52–0.83) for men. The optimal cut-off point for detecting undiagnosed diabetes was 17 (sensitivity = 48% and specificity = 73%) for the total population, 17 (sensitivity = 56% and specificity = 66%) for females, and 13 (sensitivity = 53% and specificity = 77%) for males. The positive predictive value and negative predictive value were 20% and 89.5%, respectively. The findings indicate that the Finnish questionnaire was only modestly effective in predicting undiagnosed diabetes among outpatients in Botswana.
机译:这是一项横断面研究,旨在评估芬兰糖尿病风险评分在博茨瓦纳普通内科门诊患​​者中检测未诊断的2型糖尿病的有效性。通过(1)一项8项芬兰糖尿病风险评估问卷和(2)血红蛋白A1c测试筛选了年龄≥20岁且未事先诊断出糖尿病的参与者。分析了来自291名参与者的数据(74.2%为女性)。参与者的平均年龄为50.1(SD =±11)岁,未确诊的糖尿病患病率为42(14.4%),性别之间无显着差异(20%对12.5%,P = 0.26)。总人口的未检出糖尿病曲线下面积为女性,女性为0.63(95%CI:0.56-0.75),男性为0.67(95%CI:0.56-0.75)。对于总人群而言,检测出未诊断出的糖尿病的最佳分界点是17(敏感性= 48%,特异性= 73%),女性为17(敏感性= 56%,特异性= 66%),以及13(敏感性= 53%)。男性特异性为77%)。阳性预测值和阴性预测值分别为20%和89.5%。研究结果表明,芬兰的问卷仅在预测博茨瓦纳门诊患者的未诊断出的糖尿病方面有中等效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号